WuXi AppTec company profile
Company profile
WuXi AppTec has 33,834 employees and is headquartered in Shanghai, China.
With revenue of CNY 43.4 billion in the fiscal year ended December 2025, WuXi AppTec Co., Ltd. operates as an investment holding company whose businesses span drug discovery, development and manufacturing. Its contract research, development and manufacturing services cover small molecules, oligonucleotides, peptides and complex conjugates, from discovery through to commercial production, and include biology services that run from target discovery to candidate selection and clinical entry. Through its testing arm it offers toxicology, DMPK and bioanalytical laboratory work, while its clinical research services range from Phase I to Phase IV development and bioequivalence studies for pharmaceuticals and biologics. Operations are conducted in the People's Republic of China, the United States, Europe and other markets.
Net profit reached CNY 19.2 billion in the same fiscal year, while revenue rose 21.4% from the prior year. The group employed 33,834 people and is headquartered in Shanghai, where it was founded in 2000. Its shares also trade on the Hong Kong market.
Company facts
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- China
- Headquarters
- 288 Fute Zhong Road, 200131, Shanghai
- Employees
- 33,834
- Chief executive
- Ge Li
- Founded
- 2000
- Fiscal year
- January - December
- Listing
- 603259 · SSE
- Currency
- CNY
- ISIN
- CNE1000031K4
- Website
- wuxiapptec.com
WuXi AppTec and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| WuXi AppTec603259 | China | $66.55B | 33,834 | 44.8% | 16.3 |
| WuXi XDC Cayman2268 | Hong Kong SAR China | $11.19B | 3,628 | 28.1% | 56.4 |
| Sonic HealthcareSHL | Australia | $6.67B | 47,000 | 9.3% | 16.2 |
| IDEXX LaboratoriesIDXX | United States | $55.48B | 11,000 | 32.5% | 47.0 |
| Lonza GroupLONN | Switzerland | $55.48B | 20,141 | 23.5% | 44.1 |
| Agilent TechnologiesA | United States | $49.04B | 18,200 | 24.5% | 34.3 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
